Form 4: Cencora CFO James F. Cleary Reports Stock Transactions
SEC Form 4 Filing
Cencora's Chief Financial Officer, James F. Cleary, acquired shares and disposed of shares to cover tax obligations related to performance share units.
Summary
- James F. Cleary, the Chief Financial Officer of Cencora, Inc., reported transactions involving the company's stock.
- On November 21, 2024, Mr. Cleary acquired 35,137 shares of common stock at no cost due to the vesting of performance share units.
- Also on November 21, 2024, Mr. Cleary disposed of 16,248 shares at a price of $225.08 per share to satisfy tax withholding obligations.
- Following these transactions, Mr. Cleary directly owns 137,631.3479 shares of Cencora common stock.
- Additionally, on November 20, 2024, Mr. Cleary was granted 6,250 restricted stock units, which will vest in three equal installments on November 20, 2025, 2026, and 2027.
Sentiment
Score: 6
Explanation: The document reflects routine insider transactions related to executive compensation. There are no significant positive or negative implications for the company's performance.
Positives
- The vesting of performance share units indicates that performance goals were met, which is a positive sign for the company.
- The grant of restricted stock units aligns management's interests with those of shareholders.
Negatives
- The sale of shares to cover tax obligations, while common, does reduce Mr. Cleary's direct holdings.
Risks
- There are no specific risks mentioned in this document, but it is important to monitor insider transactions for any unusual patterns.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It does not indicate any specific trend in the pharmaceutical distribution industry.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity awards, such as the performance share units and restricted stock units granted to Mr. Cleary.
- The vesting schedules for restricted stock units are typical, with vesting occurring over a period of several years to incentivize long-term performance.
- The sale of shares to cover tax obligations is a standard practice among executives who receive equity compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation practices.
- The vesting of performance share units suggests that the company is meeting its performance goals, which is a positive sign for stakeholders.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Grant date of 6,250 restricted stock units. |
| 11/21/2024 | Acquisition of 35,137 shares and disposal of 16,248 shares. |
| 11/20/2025 | First vesting date for restricted stock units. |
| 11/20/2026 | Second vesting date for restricted stock units. |
| 11/20/2027 | Third vesting date for restricted stock units. |
| 11/22/2024 | Date of filing of the Form 4. |
Keywords
Cencora, Insider Trading, Form 4, James F. Cleary, Stock Transactions, Restricted Stock Units, Performance Share Units, Chief Financial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.